Physician profile
Aaron E Lech
NPI 1053365254
$99,842.17
in general payments reported to CMS, 2019-2025
19 companies · $3,365 in 2025
The $3,365 reported for 2025 was more than what 98% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $38K · 2020: $20K · 2021: $6,842 · 2022: $4,432 · 2023: $1,232 · 2024: $26K · 2025: $3,365.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $28K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,600 · Food and Beverage: $820.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $28,400.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,600.00 |
| Food and Beverage | $820.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec, INC. | $93,114.86 | 2019-2025 | Clarus, Forum Glaucoma Workplace, Retina Workplace |
| Allergan, INC. | $2,462.68 | 2019-2021 | |
| Novo Nordisk As | $1,790.16 | 2019 | |
| Carl Zeiss Meditec USA, INC. | $1,127.08 | 2021-2024 | Cirrus Hd-Oct |
| Tarsus Pharmaceuticals, INC. | $520.72 | 2024-2025 | Xdemvy |
| Johnson & Johnson Vision Care, INC. | $226.80 | 2019-2025 | Acuvue |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $115.89 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $113.45 | 2022-2025 | Infuse |
| Sun Pharmaceutical Industries INC. | $64.01 | 2019-2025 | |
| Genentech USA, INC. | $54.11 | 2019 | |
| Glaukos Corporation | $52.11 | 2022 | |
| Abbvie INC. | $45.62 | 2022 | |
| Alcon Vision LLC | $35.70 | 2020-2024 | Precision 1 |
| Biotissue Holdings INC. | $33.55 | 2025 | |
| Coopervision INC. | $29.75 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $26.19 | 2022 | |
| Maculogix, INC. | $15.33 | 2021 | |
| Novartis Pharmaceuticals Corporation | $14.16 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Lech listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.